About Mankind Pharma
Mankind Pharma was incorporated in 1991 and operates in the 130,182.00 segment. The shares listed at ₹1,300.00, a 20.37% move from the issue price. Mankind Pharma is a Mainboard IPO with an issue size of ₹4,326.36 crore, proposed for listing on BSE, NSE. The offer opens on 25th Apr 2023 and closes on 27th Apr 2023. The issue structure includes an offer-for-sale component of ₹4,326.36 crore. The current listing schedule points to 9th May 2023.
Company Contact
Address—
Phone—
Websitehttps://www.ipomatrix.com/